Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives

Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives

Elena Niculet,1,2,* Carmen Bobeica,1 Ioana Anca Stefanopol,1,3 Ana Maria Pelin,4,* Alexandru Nechifor,2,5,* Cristian Onisor,1,* Alin Laurentiu Tatu2,4,5 1Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, “Dunărea de Jos”...

Full description

Bibliographic Details
Main Authors: Niculet E, Bobeica C, Stefanopol IA, Pelin AM, Nechifor A, Onisor C, Tatu AL
Format: Article
Language:English
Published: Dove Medical Press 2022-04-01
Series:Therapeutics and Clinical Risk Management
Subjects:
abrocitinib
atopic dermatitis
adolescents
jade
jade-mono
Online Access:https://www.dovepress.com/once-daily-abrocitinib-for-the-treatment-of-moderate-to-severe-atopic--peer-reviewed-fulltext-article-TCRM

Internet

https://www.dovepress.com/once-daily-abrocitinib-for-the-treatment-of-moderate-to-severe-atopic--peer-reviewed-fulltext-article-TCRM

Similar Items